ICİlKnur Aytekin Celik

İlKnur Aytekin Celik

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


İlKnur Aytekin Celik has a total of 34 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Tumor volume may be a better indicator than diameter for occult lymph node metastasis in patients with clinical stage-1 lung cancer

    by Muhammet Sayan, Ilknur Aytekin Celik, Mahir Fattahov, Bengisu Artiran, Ismail Cuneyt Kurul, Ali Celik

    Occult lymph node metastasis (OLM) remains a major clinical challenge in patients with lung cancer despite comprehensive preoperative staging efforts. Although several predictors of OLM, including tumor diameter, metabolic activity, molecular characteristics, and radiomics, have been extensively investigated, the predictive role of tumor volume remains poorly defined. This study aimed to evaluate whether tumor volume, quantified semi-automatically using artificial intelligence (AI)-assisted Synapse 3D software, could predict OLM in patients with clinically early-stage lung cancer. Patients who underwent surgical resection for clinically staged cT1b–cN0M0 lung cancer between 2018 and 2024 were included. Tumor volume was quantified using Synapse 3D software. Associations between tumor volume and OLM were assessed using univariable and multivariable logistic regression analyses. Because tumor diameter and tumor volume may introduce multicollinearity in multivariable models, separate receiver operating characteristic (ROC) curves were generated, and the corresponding areas under the curve (AUCs) were compared using the DeLong test. A total of 248 patients were included, of whom 59 (23.8%) were female. The mean age was 65.4 years. OLM were identified in 10.8%, 4.8%, and 2.0% of patients at the N1, N2a, and N2b nodal stations, respectively. Multivariable logistic regression identified younger age (p = 0.004), greater tumor volume (p = 0.01), and histopathological subtypes other than adenocarcinoma and squamous cell carcinoma as independent predictors of OLM. Tumor diameter, extent of resection, surgical approach, and PET-CT metabolic activity were not significantly associated with OLM. ROC analysis demonstrated that tumor volume had significantly greater discriminatory ability for predicting OLM than tumor diameter (AUC: 69% vs. 58%; DeLong test, p = 0.004). AI-assisted tumor volumetry is an independent predictor of occult lymph node metastasis in patients with clinically early-stage lung cancer. Graphical abstract

  • Open Access

    Is intrapleural sericin administration toxic to the nervous system of rats?

    by Alkın Yazıcıoğlu, İlKnur Aytekin Çelik, Mahmut Subaşı, Funda Demirağ, Nurettin Karaoğlanoğlu

    Is intrapleural sericin administration toxic to the nervous system of rats? - Turkish Journal of Thoracic and Cardiovascular Surgery

  • Open Access

    Experience of Lung Surgery in the COVID-19 Pandemic

    by Kubilay İnAn, İlKnur Aytekin Çelik, Nurettin Karaoğlanoğlu

    Objective: During the pandemic, elective cases other than those requiring emergency thoracic surgery were postponed. Depending on the magnitude of the impact the pandemic posed on hospitals and clinics, there have been changes in the number and variety of cases of thoracic surgery. The intention behind conducting this study was to share the experiences gained by a thoracic surgery clinic during the pandemic period.Methods: Altogether, 214 patients were included in the study. Patient data that were recorded included those on age, gender, lung pathology, duration of hospital stay, positivity for COVID-19, survival, and causes of death.Results: Of the 214 patients operated on, 12 died during the postoperative period. Eight of these patients died due to their primary disease and one died due to gastrointestinal bleeding, whereas the remaining three patients died due to COVID-19 infection.Conclusions: If opportunities and facilities favorable for the administration of surgical treatment are made available, surgical treatment services can be offered safely to all patients

  • Open Access

    Survival and Stage in Lung Cancer

    by Kubilay İnAn, Merve Şengül İnAn, İlKnur Ayteki̇n Çeli̇k, Ozgur Omer Yi̇lDi̇z, Nurettin Karaoglanoglu

    Aim of study: Lung cancer is the leading cause of cancer death worldwide. Although the 5-year survival rates of for non-small cell lung carcinoma (NSCLC) ranges from 20% to 70%. The present study investigates the rates of early recurrence in a total of 83 patients operated for NSCLC and presents the related findings in reference to the data available in the literature. Materials and Methods: Patients who underwent lung resection for malignancy between March 2019 and September 2021 were retrospectively examined. The patient data, including age, gender, presence of preoperative chemotherapy administration, operations performed, operation dates, pathology results, postoperative staging, survival, and relapses, were documented. Ethical approval for this study was obtained from the ethics committee of Ankara Bilkent City Hospital. Approval number is E1-20-817 Results: A total of 83 patients who underwent lung resection for malignancy between March 2019 and September 2021 were examined. The patients had a median age of 62 years. Of the total number of patients four patients developed recurrence and 79 continued their follow-up without any recurrence. Of the patients who underwent lung resection, eight (9.6%) patients died within the first postoperative 2-year period. The mean survival period of these eight patients was 14.6 months (7–20 months). Conclusion: Although various parameters, such as age, gender, pathological type, and location of the tumor are examined and compared, according to the available data on the long-term survival of surgical patients, it is known that the only parameter that affects survival is the pathological stage of the patient.

  • Open Access

    Primary lung tumors invading the chest wall

    by Merve Şengül İnAn, Kubilay İnAn, İlKnur Ayteki̇n Çeli̇k, Nurettin Karaoglanoglu

    Objective: Lung cancer remains the leading cause of cancer deaths worldwide. The surgical approach to locally advanced non-small cell lung cancer (NSCLC) goes beyond the classical approach and requires a multidisciplinary approach both preoperatively and postoperatively. In addition to the tumor size, the location of T3 tumors affects the extent of the surgery. Materials and Methods: Patients who underwent lung resection for cancer between March 2019 and October 2022 were retrospectively reviewed. Patients who underwent chest wall resection were evaluated in terms of age, gender, pathology, type of operation, survival, recurrence, complications, receipt of preoperative chemotherapy, tumor node metastasis (TNM) stage, whether or not mediastinoscopy was performed, STAS (The spread through air spaces) positivity, visceral pleural invasion, parietal pleural invasion, lymphovascular invasion, perineural invasion, and alveolar/bronchial wall invasion. Results: Thoracic wall resection was performed in nine patients with locally advanced NSCLC. The use of prolene mesh was required in eight patients. All patients complained of pain in the thoracic wall in the preoperative period. Postoperative pathology results showed STAS positivity in four patients; alveolar/bronchial wall invasion in four; and visceral, parietal, pleural, and lymphovascular invasion in seven. The mean survival of the patients was 24.20 months (0.63–39). No patient developed recurrence during the follow-up period. Conclusion: Chest wall resection and reconstruction for lung cancer is a surgical treatment method that should be performed without violating respiratory physiology and by using a small amount/number of synthetic materials.

  • Open Access

    Evaluation of the effect of intraoperative frozen section on overall timeliness and survival in lung cancer surgery

    by Merve Şengül İnan, Kubilay İnan, İlknur Ayteki̇n Çeli̇k, Nurettin Karaoglanoglu

    Background/Aim: We aimed to find out whether there is any delay in the management of the process in patients operated on for lung cancer and to understand the effect of intraoperative frozen section on this process. Methods: 176 patients were analyzed in total. The dates of admission, diagnosis, operation, and postoperative pathology results were noted. Five intervals were defined as time from first evaluation to diagnosis, first evaluation to surgery, diagnosis to surgery, first evaluation to the day of the postoperative pathology report, and diagnosis to the day of the postoperative pathology report. Results: The majority of patients (81.8%) were male, and the median age was 63 years (iqr = 11). The median time between the first assessment and the final pathological examination result was 62 days (iqr = 70). The time from initial presentation to surgery was significantly shorter (p 0.001), and the time from diagnosis to final pathology was also significantly shorter (p 0.001) in patients diagnosed by frozen section. However, there was no significant difference in the time from initial evaluation to diagnosis between the two groups (0.052). There was no significant difference in survival between patients diagnosed by freezing and patients diagnosed by other methods (p = 0.508). Conclusion: Solutions to increase the timeliness of care for patients with lung cancer can be designed with a better understanding of delays. Intraoperative frozen section diagnosis improves overall timeliness but has no effect on survival in lung cancer patients undergoing surgery.

  • Open Access

    Analysis of the factors that affect survival among patients who developed subcutaneous emphysema monitored on COVID-19 diagnosis: single-centred research

    by Tamer Di̇rek, Kubilay İnan, Merve Şengül İnan, Mehmet Furkan Şahi̇n, İlknur Ayteki̇n Çeli̇k, Nurettin Karaoglanoglu

    Aim: The COVID-19 patients with pulmonary involvement frequently develop pneumothorax, pneumomediastinum and subcutaneous emphysema due to barotrauma. Reviewing the literature, pneumothorax, pneumomediastinum and subcutaneous emphysema it can be observed among ICU patients due to the pulmonary involvement of the COVID-19 disease, and therefore, can cause mortality and morbidity. This study aims to analyse the factors that affect mortality in COVID-19 patients in ICUs who develop subcutaneous emphysema. Material and Method: A total of 854 COVID-19 patients who were consulted from all branches in the Chest Surgery Clinic of Ankara City Hospital between September 1, 2020 - March 1, 2021 were retrospectively analyzed. Demographic characteristics, comorbid diseases and COVID-related tests (LDH, D-dimer, procalcitonin, ferritin, CRP, IL-6, lymphocyte percentage and neutrophil and lymphocyte ratio) imaging results and survival of 66 patients with subcutaneous emphysema were analyzed. Results: Of the patients, 41 (62%) were male and 25 (38%) were female. The mean age was 63 years. 55 (83%) of these patients were followed up with invasive ventilation support due to general health impairment, increased oxygen demand and heart problems. Age, intubation and NLR were found to be statistically significant in terms of survival and death, on survival. It was discovered that age and intubation variables could be risk factors. The mortality rates were 1.01 times higher for the elderly compared to the younger patients and 13.8 times higher for the intubated compared to the non-intubated patients. Conclusion: Age of patient and intubation can be regarded as risk factors for mortality in COVID-19 patients with subcutaneous emphysema, monitored in ICUs. Furthermore, comorbid diseases increase mortality rates.

  • COVID-19 Pandemisi Sırasında Göğüs Cerrahisi Kliniği Deneyimimiz

    by Kubilay İnan, İlknur Ayteki̇n Çeli̇k, Ozgur Omer Yi̇ldi̇z, Tamer Di̇rek, Nurettin Karaoglanoglu

    Aim : During the COVID-19 pandemic, all elective surgeries, except emergency surgeries and surgeries for patients with malignancy, were postponed. However, thoracic surgery clinics continued to operate during the pandemic. In this study, patients who presented to the thoracic surgery clinic of our hospital during and those who presented before the COVID-19 pandemic were compared, and changes in characteristics of the patients presenting to the thoracic surgery clinic during the COVID-19 pandemic were investigated. Materials and methods: Age, gender, and reason for admission to the hospital were documented for all patients who presented to the thoracic surgery clinic of our hospital during March 2019–March 2020 and March 2020–March 2021. Patients presenting to the clinic were categorized into malignancy, trauma, chest pain, pneumothorax, and other disease groups. Results: In total, 947 patients presented to the clinic in the prepandemic period. Conversely, 756 patients presented to the clinic during the pandemic. In the prepandemic period, 353 patients presented with trauma; this number decreased to 154 during the pandemic. Additionally, during the pandemic, a decrease was observed in all patient admissions other than those due to malignancies. Conclusion: During the pandemic, there has been a decrease in patient admissions due to trauma, mostly as a result of curfews and restrictions. However, there has been a significant increase in the number of patients presenting with lung malignancies during the pandemic. This may be due to findings of incidental lung masses in the thoracic computed tomography performed after COVID-19 prediagnosis.

  • Open Access

    Benign Diseases of The Lung

    by İlKnur Aytekin Çelik, Özgür Ömer Yıldız, Nurettin Karaoğlanoğlu

  • Open Access

    Tracheal and Airway Diseases

    by İlKnur Aytekin Çelik, Nurettin Karaoğlanoğlu